LSD Therapy Reduces Anxiety in Major Clinical Trial

A pharmaceutical company's LSD pill significantly reduced anxiety in 214 patients during a Phase 3 trial, marking the second major mental health breakthrough for psychedelic medicine this year.

The treatment follows successful results for depression just two months earlier.